Skip to content

Postpartum Uterine Curettage in the Recovery From Preeclampsia/Eclampsia

Effects of Postpartum Uterine Curettage in the Recovery From Preeclampsia/Eclampsia: A Randomized, Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03028194
Enrollment
442
Registered
2017-01-23
Start date
2015-10-01
Completion date
2016-12-11
Last updated
2017-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eclampsia, Pre-Eclampsia

Keywords

Pre-eclampsia, Eclampsia, Postpartum uterine curettage

Brief summary

Use of Postpartum uterine curettage in reducing hospitalization time or in improving the clinical evolution of the patient with preeclampsia/eclampsia.

Detailed description

To evaluate if postpartum uterine curettage improved the clinical and laboratory parameters in patients with preeclampsia or eclampsia. A total of 442 patients with preeclampsia/eclampsia were randomized to postpartum curettage (223) or no procedure (219). Systolic and diastolic blood pressure were recorded and analyzed at hours 6, 12, 24 and 48. Also, several laboratory values and diuresis were evaluated.

Interventions

PROCEDURECurettage

Postpartum uterine curettage with a sharp curette # 14 or #16, immediately after delivery of the placenta.

PROCEDUREPlacebo

No procedure after delivery of the placenta

Sponsors

Saint Thomas Hospital, Panama
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
15 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Gestational age 24 weeks or more. * Preeclampsia/eclampsia

Exclusion criteria

* Epilepsy or seizures previous to pregnancy. * Renal disease * Heart disease * Liver disease

Design outcomes

Primary

MeasureTime frameDescription
Systolic and diastolic blood pressure6 hoursArterial blood pressure

Secondary

MeasureTime frameDescription
Laboratory results (hypertensive disorder profile: hemoglobin, hematocrit, platelets, renal or liver function tests).6 hoursNumber of patients with an abnormal laboratory value
Seizures48 hoursNumber of participants with the development of seizures after birth.

Countries

Panama

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026